SNDXSyndax Pharmaceuticals, Inc.
$13.40-11% 1Y
$13.40
$12.9252 weeks$25.15
Is the price fair?
What SNDX's price assumes
Syndax Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 4.74× revenue.
4.74
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 79.3
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 3.96
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 79.3
- EV / EBIToperating margin −77%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 3.96
- Market capitalisation89.3 million shares, counted Jul 31, 2026
- $1.20B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.